James W. Gillespie graduated from Auburn University with a BS in Biochemistry (2007) and completed a Ph.D. in Biomedical Sciences (2015). In 2016, he joined the faculty of the College of Veterinary Medicine at Auburn University as a Research Assistant Professor. He has served as Key Personnel and Co-PI on grants from the NIH-NCI and AURIC. He is a member of the American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), Auburn University Research Initiative in Cancer (AURIC), and the National Cancer Institute Alliance for Nanotechnology in Cancer (2009-2015). His current research interests include phage display, development of precision nanomedicines, and prevention/diagnosis/treatment of neoplastic and infectious deceases. James W. Gillespie graduated from Auburn University with a BS in Biochemistry (2007) and completed a Ph.D. in Biomedical Sciences (2015). In 2016, he joined the faculty of the College of Veterinary Medicine at Auburn University as a Research Assistant Professor. He has served as Key Personnel and Co-PI on grants from the NIH-NCI and AURIC. He is a member of the American Association of Pharmaceutical Scientists (AAPS), American Chemical Society (ACS), Auburn University Research Initiative in Cancer (AURIC), and the National Cancer Institute Alliance for Nanotechnology in Cancer (2009-2015). His current research interests include phage display, development of precision nanomedicines, and prevention/diagnosis/treatment of neoplastic and infectious deceases.

Vaccines & Vaccination, Veterinary and Animal Sciences